Acute Renal Failure and Its Risk Factors in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

被引:54
作者
Hung, Chi-Chih [1 ]
Liu, Wan-Chun [1 ]
Kuo, Mei-Chuan [1 ]
Lee, Chih-Hung [2 ]
Hwang, Shang-Jyh [1 ]
Chen, Hung-Chun [1 ]
机构
[1] Kaohsiung Med Univ, Dept Internal Med, Div Nephrol, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung 807, Taiwan
关键词
Acute interstitial nephritis; Acute renal failure; Erythema multiforme; Hypersensitivity; ERYTHEMA MULTIFORME; NEPHRITIS; MARKER;
D O I
10.1159/000195632
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Skin lesion is the most frequent manifestation of adverse drug reactions. Drug-induced cutaneous hypersensitivity and drug-induced acute interstitial nephritis might share a similar mechanism involving drug-specific T cells. We thus investigated the renal outcome of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the most severe drug-induced cutaneous hypersensitivity, and hypothesize that skin detachment in SJS/TEN might be associated with acute renal failure (ARF). Methods: 234 hospitalized patients were retrospectively classified into an SJS/TEN group (skin detachment) or an erythematous multiforme majus group (target-like exanthema alone). Results: Both drugs and chronic kidney disease (CKD) are associated with SJS/TEN. The SJS/TEN group was more likely to develop ARF than the erythematous multiforme majus group (18.8 vs. 4.3%, p < 0.05) despite similar initial creatinine clearance. In the ARF patients, RIFLE-F class, dialysis and long-term dialysis were 25, 15 and 5%, respectively. The offending drugs in ARF were also associated with CKD. Hyponatremia and late hypokalemia were more frequently in the SJS/TEN group (15.6 vs. 2.9%, 7.3 vs. 0.7%, respectively, p < 0.05). Sepsis, allopurinol, antibiotics, NSAIDs, CKD and hypoalbuminemia (OR: 18.8, 9.8, 10.1, 9.0, 5.3 and 3.3, respectively, p < 0.05) were the risk factors of developing ARF. Conclusion: ARF, the need for dialysis, and late hypokalemia could be the consequences of SJS/TEN. Skin detachment after certain medication might implicate the associated ARF, especially in CKD patients. Copyright (c) 2009 S. Karger AG, Basel
引用
收藏
页码:633 / 638
页数:6
相关论文
共 20 条
[1]   Primary care:: Hyponatremia. [J].
Adrogué, HJ ;
Madias, NE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1581-1589
[2]   Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study [J].
Auquier-Dunant, A ;
Mockenhaupt, M ;
Naldi, L ;
Correia, O ;
Schroder, W ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2002, 138 (08) :1019-1024
[3]   SCORTEN: A severity-of-illness score for toxic epidermal necrolysis [J].
Bastuji-Garin, S ;
Fouchard, N ;
Bertocchi, M ;
Roujeau, JC ;
Revuz, J ;
Wolkenstein, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :149-153
[4]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[5]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[6]   The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum [J].
Caproni, M ;
Torchia, D ;
Schincaglia, E ;
Volpi, W ;
Frezzolini, A ;
Schena, D ;
Marzano, A ;
Quaglino, P ;
Simone, C ;
Parodi, A ;
Barletta, E ;
Fabbri, P .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (02) :319-324
[8]   A marker for Stevens-Johnson syndrome [J].
Chung, WH ;
Hung, SI ;
Hong, HS ;
Hsih, MS ;
Yang, LC ;
Ho, HC ;
Wu, JY ;
Chen, YT .
NATURE, 2004, 428 (6982) :486-486
[9]   Acute interstitial nephritis: clinical features and response to corticosteroid therapy [J].
Clarkson, MR ;
Giblin, L ;
O'Connell, FP ;
O'Kelly, P ;
Walshe, JJ ;
Conlon, P ;
O'Meara, Y ;
Dormon, A ;
Campbell, E ;
Donohoe, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) :2778-2783
[10]   The effect of chronic renal failure on hepatic drug metabolism and drug disposition [J].
Dreisbach, AW ;
Lertora, JJL .
SEMINARS IN DIALYSIS, 2003, 16 (01) :45-50